Doula Combined Latent Phrase Epidural Analgesia in Primiparous Women
NCT ID: NCT00664118
Last Updated: 2009-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
500 participants
INTERVENTIONAL
2008-04-30
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Labor Analgesia in the Latent Phrase
NCT00647725
Comparison of Combined Spinal-epidural Analgesia Versus Epidural Analgesia for Pain Management During Labor
NCT03600272
Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes
NCT02008591
Intravenous Remifentanil for Labor Analgesia
NCT00710086
The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia
NCT01708668
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Doula combined epidural analgesia in the latent phase of first stage of labor
Doula combined analgesia
Doula combined epidural analgesia in the latent phase of first stage of labor in primiparas
2
Epidural analgesia in the latent phase of the first stage of labor without doula accompany
Analgesia without doula
Epidural analgesia in the latent phase of first stage of labor without doula accompany in primiparas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Doula combined analgesia
Doula combined epidural analgesia in the latent phase of first stage of labor in primiparas
Analgesia without doula
Epidural analgesia in the latent phase of first stage of labor without doula accompany in primiparas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18 years and \< 45 years
* Spontaneous labor
* Analgesia request
Exclusion Criteria
* Participants younger than 18 years or older than 45 years
* Those who were not willing to or could not finish the whole study at any time
* Using or used in the past 14 days of the monoamine oxidase inhibitors;
* Alcohol addictive or narcotic dependent patients were excluded for their influence on the analgesic efficacy of the epidural analgesics
* Subjects with a nonvertex presentation or scheduled induction of labor
* Cervical dilation was 4.0 cm or greater before performing epidural puncture and catheterization
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HRSA/Maternal and Child Health Bureau
FED
Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nanjing Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
XiaoFeng Shen, MD
Role: STUDY_DIRECTOR
Nanjing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanjing Maternal and Child Health Care Hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NMUC-08022
Identifier Type: -
Identifier Source: secondary_id
NMCHCH-0121-236
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.